Stockholders' Equity |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Stockholders' Equity | |
| Stockholders' Equity | Note 13. Stockholders’ Equity The Company is authorized to issue up to 680,000,000 shares of common stock, without any par value per share. Each holder of common stock is entitled to one vote for each share held of record on all matters to be voted on by such holders. Holders of common stock are entitled to receive dividends, if declared. Upon liquidation, dissolution or winding-up, holders of common stock are entitled to share ratably in the net assets legally available for distribution after payment of all debts and other liabilities, subject to any preferential rights of the holders of preferred stock, if any. During the three months ended March 31, 2026, approximately 0.4 million shares of common stock vested or were issued to the Company’s board of directors, officers, employees, and advisors in settlement of an equal number of fully vested restricted stock awards (“RSAs”) or restricted stock units (“RSUs”) awarded to such individuals by the Company under the Company’s 2019 Equity Incentive Plan, as amended (the “2019 Equity Incentive Plan”). The Company withheld approximately 0.2 million of these shares, with a fair value of approximately $2.0 million, to cover taxes related to the settlement of such vested RSAs and RSUs, as permitted by the 2019 Equity Incentive Plan. At-the-Market Equity (“ATM”) Program In December 2025, the Company established the 2025 ATM program, under which it could offer and sell up to $500.0 million in shares of the Company’s common stock (the “2025 ATM Program”). During the three months ended March 31, 2026, no shares were sold under the 2025 ATM Program, and as of March 31, 2026, all $500.0 million in shares of the Company’s common stock were available for sale under the 2025 ATM Program.
|